Growth Hormone Response to Arginine in Normal Subjects and in Patients with Chemical Diabetes and Effect of Clofibrate and of Metergoline
- 1 June 1977
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 155 (2) , 160-163
- https://doi.org/10.3181/00379727-155-39765
Abstract
Summary The growth hormone response to arginine infusion was greater in normal females than in normal males and was impaired in patients with obesity and/or elevated serum triglyceride levels, but with normal glucose tolerance. In patients with chemical diabetes these differences were smaller and were not statistically significant. Both clofibrate, a hypolipemic agent, and metergoline, an antiserotonin drug, enhanced GH response to arginine in normal subjects, but not in patients with CD.Keywords
This publication has 0 references indexed in Scilit: